Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study

Por Ng, Khai P., Stringer, Stephanie J., Jesky, Mark D., Yadav, Punit, Athwal, Rajbir, Dutton, Mary, Ferro, Charles J., Cockwell, Paul
Publicado em 2014

Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial

Por Ng, Khai P, Jain, Poorva, Gill, Paramjit S, Heer, Gurdip, Townend, Jonathan N, Freemantle, Nick, Greenfield, Sheila, McManus, Richard J, Ferro, Charles J
Publicado no BMJ Open (2016)

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial

Por Ng, Khai P, Jain, Poorva, Heer, Gurdip, Redman, Val, Chagoury, Odette L, Dowswell, George, Greenfield, Sheila, Freemantle, Nick, Townend, Jonathan N, Gill, Paramjit S, McManus, Richard J, Ferro, Charles J
Publicado em 2014